Chronic myelogenous leukemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:
*[[Acute myeloid leukemia]]
*[[Acute myeloid leukemia]]
*[[Thrombocytosis]]
*[[Thrombocytosis]]
=Differenting Chronic lymphocytic leukemia from other Diseases==
* Chronic lymphocytic leukemia must be differentiated from other diseases that cause [[weight loss]],  [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].
* Based on the expression of cell surface markers, the table below differentiates chronic lymphocytic leukemia from other diseases that cause similar clinical presentations:<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
<br>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
|valign=top|
|+
! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Surface Immunoglobulin'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD5'''}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''CD22/FMC7'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD23'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD79b'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD103'''}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Chronic lymphocytic leukemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Weakly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive/Negative'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Prolymphocytic leukemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Hairy cell leukemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive/Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Mantle cell lymphoma'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Follicular lymphoma'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''
|}
<br>
* Chronic lymphocytic leukemia must also be differentiated from other causes of fever, hepatosplenomegaly, and lymph node swelling such as:<ref name="wiki">Chronic Lymphocytic Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October ,12 2015</ref>
:* [[Splenic marginal zone lymphoma]]
:* Nodal marginal zone [[lymphoma]]
:* [[Lymphoplasmacytic lymphoma]]
:* [[Sézary syndrome]]
:* Smoldering [[adult T cell leukemia]]


==References==
==References==

Revision as of 13:53, 21 July 2017

Chronic myelogenous leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic myelogenous leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic myelogenous leukemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic myelogenous leukemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic myelogenous leukemia differential diagnosis

CDC on Chronic myelogenous leukemia differential diagnosis

Chronic myelogenous leukemia differential diagnosis in the news

Blogs on Chronic myelogenous leukemia differential diagnosis

Directions to Hospitals Treating Chronic myelogenous leukemia

Risk calculators and risk factors for Chronic myelogenous leukemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Chronic myelogenous leukemia must be differentiated from leukemoid reaction, chronic neutrophilic leukemia, and acute myeloid leukemia.[1]

Differential Diagnosis

Chronic myelogenous leukemia must be differentiated from:[1][2][3]

  • Leukemoid reaction associated with:

Differenting Chronic lymphocytic leukemia from other Diseases=


Differential Diagnosis Surface Immunoglobulin CD5 CD22/FMC7 CD23 CD79b CD103

Chronic lymphocytic leukemia

Weakly positive

Positive

Negative

Positive

Negative

Positive/Negative

Prolymphocytic leukemia

Strongly positive

Negative

Positive

Negative

Positive

Negative

Hairy cell leukemia

Strongly positive

Negative

Positive

Negative

Positive/Negative

Positive

Mantle cell lymphoma

Positive

Positive

Strongly positive

Negative

Strongly positive

Negative

Follicular lymphoma

Strongly positive

Negative

Positive

Negative

Strongly positive

Negative


  • Chronic lymphocytic leukemia must also be differentiated from other causes of fever, hepatosplenomegaly, and lymph node swelling such as:[5]

References

  1. 1.0 1.1 Gajendra S, Gupta R, Chandgothia M, Kumar L, Gupta R, Chavan SM (2014). "Chronic Neutrophilic Leukemia with V617F JAK2 Mutation". Indian J Hematol Blood Transfus. 30 (2): 139–42. doi:10.1007/s12288-012-0203-6. PMC 4022913. PMID 24839370.
  2. Kanegae MP, Ximenes VF, Falcão RP, Colturato VA, de Mattos ER, Brunetti IL; et al. (2007). "Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay". J Clin Lab Anal. 21 (2): 91–6. doi:10.1002/jcla.20140. PMID 17385676.
  3. Jabbour E, Kantarjian H (2014). "Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management". Am J Hematol. 89 (5): 547–56. doi:10.1002/ajh.23691. PMID 24729196.
  4. Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011
  5. Chronic Lymphocytic Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October ,12 2015


Template:WikiDoc Sources